G856-0761 Screening compound: 2-({3-methyl-4-oxo-3H,4H,5H-pyrimido[5,4-b]indol-2-yl}sulfanyl)-N-(1,3-thiazol-2-yl)acetamide

G856-0761 Screening compound: 2-({3-methyl-4-oxo-3H,4H,5H-pyrimido[5,4-b]indol-2-yl}sulfanyl)-N-(1,3-thiazol-2-yl)acetamide
G856-0761 Screening compound: 2-({3-methyl-4-oxo-3H,4H,5H-pyrimido[5,4-b]indol-2-yl}sulfanyl)-N-(1,3-thiazol-2-yl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G856-0761
2-({3-methyl-4-oxo-3H,4H,5H-pyrimido[5,4-b]indol-2-yl}sulfanyl)-N-(1,3-thiazol-2-yl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G856-0761

Molecular Formula

C16H13N5O2S2 (C16 H13 N5 O2 S2)

Compound Name

2-({3-methyl-4-oxo-3H,4H,5H-pyrimido[5,4-b]indol-2-yl}sulfanyl)-N-(1,3-thiazol-2-yl)acetamide

IUPAC name

2-({3-methyl-4-oxo-3H4H5H-pyrimido[54-b]indol-2-yl}sulfanyl)-N-(13-thiazol-2-yl)acetamide

SMILES

CN(C1=O)C(SCC(Nc2nccs2)=O)=Nc2c1[nH]c1c2cccc1

InChI

InChI=1S/C16H13N5O2S2/c1-21-14(23)13-12(9-4-2-3-5-10(9)18-13)20-16(21)25-8-11(22)19-15-17-6-7-24-15/h2-7,18H,8H2,1H3,(H,17,19,22)

InChI Key

BQEUEJDUFHTZCD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD04458140

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

371.44

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.903

Distribution Coefficient, logD

1.902

Water Solubility, LogSw

-2.51

Polar Surface Area

67.394

Acid Dissociation Constant (pKa)

10.55

Base Dissociation Constant (pKb)

0.37

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

12.50

G856-0761 in Drug Discovery

Included in Screening Libraries

Cysteine Proteases Inhibitors Library (7839 compounds)

DGK Inhibitors Library (10558 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases
  • Kinases

References: we are preparing a list of scientific research reports with G856-0761 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G856-0761?
Check Price and Availability of G856-0761, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G856-0761 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G856-0761
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G856-0761
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G856-0761 available by request